| The costs of using unauthenticated, over-passaged cell lines: how much more data do we need? P Hughes, D Marshall, Y Reid, H Parkes, C Gelber Biotechniques 43 (5), 575-586, 2007 | 534 | 2007 |
| Glucagon-like peptide 1 (glp-1) pharmaceutical formulations MJ Hokenson, D Brandt, M King, S Greene, M Faris, K Oberg, ... US Patent App. 11/735,957, 2008 | 135 | 2008 |
| Cell transport compositions and uses thereof C Gelber, K Rousseau US Patent App. 10/632,878, 2004 | 130 | 2004 |
| Reversal of the metastatic phenotype in Lewis lung carcinoma cells after transfection with syngeneic H-2Kb gene. D Plaksin, C Gelber, M Feldman, L Eisenbach Proceedings of the National Academy of Sciences 85 (12), 4463-4467, 1988 | 126 | 1988 |
| Isolation of nonobese diabetic mouse T-cells that recognize novel autoantigens involved in the early events of diabetes C Gelber, L Paborsky, S Singer, D McAteer, R Tisch, C Jolicoeur, ... Diabetes 43 (1), 33-39, 1994 | 64 | 1994 |
| Methods and compositions for minimizing accrual of inhalable insulin in the lungs C Gelber, A Boss | 63 | 2006 |
| Compositions for treatment or prevention of bioterrorism SS Steiner, C Gelber, RS Feldstein, R Pohl US Patent 6,991,779, 2006 | 62 | 2006 |
| Cell Transport Compositions and Uses Thereof C Gelber, K Rousseau US Patent App. 12/471,260, 2009 | 61 | 2009 |
| Establishment of the first international repository for transfusion‐relevant bacteria reference strains: ISBT working party transfusion‐transmitted infectious diseases (WP‐TTID … M Störmer, A Arroyo, J Brachert, H Carrero, D Devine, JS Epstein, ... Vox sanguinis 102 (1), 22-31, 2012 | 54 | 2012 |
| Low-density lipoprotein receptor–related protein-1 is a therapeutic target in acute myocardial infarction S Toldo, D Austin, AG Mauro, E Mezzaroma, BW Van Tassell, C Marchetti, ... Basic to Translational Science 2 (5), 561-574, 2017 | 41 | 2017 |
| Cell transport compositions and uses thereof C Gelber, K Rousseau US Patent App. 14/752,665, 2015 | 37 | 2015 |
| Abolishment of Metastasis Formation by Murine Tumor Cells Transfected with “Foreign” H-2K Genes C Gelber, D Plaksin, E Vadai, M Feldman, L Eisenbach Cancer research 49 (9), 2366-2373, 1989 | 37 | 1989 |
| Compositions and methods for diagnosis and treatment for type 2 diabetes C Gelber, L Liu, Z Xie, P Ikonomi, JR Simms, CR Auge US Patent App. 11/901,925, 2008 | 28 | 2008 |
| Compositions and methods for diagnosis and treatment of type 2 diabetes C Gelber, L Liu, Z Xie, P Ikonomi, JR Simms, CR Auge US Patent App. 12/776,601, 2010 | 23 | 2010 |
| Down-regulation of poison ivy/oak-induced contact sensitivity by treatment with a class II MHC binding peptide: hapten conjugate. C Gelber, L Gemmell, D McAteer, M Homola, P Swain, A Liu, KJ Wilson, ... Journal of immunology (Baltimore, Md.: 1950) 158 (5), 2425-2434, 1997 | 22 | 1997 |
| T-cell subset analysis of Lewis lung carcinoma tumor rejection: heterogeneity of effectors and evidence for negative regulatory lymphocytes correlating with metastasis C Gelber, L Eisenbach, M Feldman, RS Goodenow Cancer research 52 (23), 6507-6515, 1992 | 22 | 1992 |
| Compositions and methods for diagnosis and treatment of type 2 diabetes C Gelber, L Liu, Z Xie, P Ikonomi, JR Simms, CR Auge US Patent App. 12/319,883, 2009 | 20 | 2009 |
| Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof C Gelber US Patent 6,376,654, 2002 | 20 | 2002 |
| A new small cell lung cancer (SCLC)-specific marker discovered through antigenic subtraction of neuroblastoma cells P Krueger, C Nitz, R Foster, C MacDonald, O Gelber, G Lalehzadeh, ... Cancer Immunology, Immunotherapy 52, 367-377, 2003 | 18 | 2003 |
| H‐2Db gene transfer into highly metastatic D122 cells results in tumor rejection in allogeneic recipients, but does not affect metastasis in syngeneic recipients … D Plaksin, C Gelber, L Eisenbach International journal of cancer 52 (5), 771-777, 1992 | 13 | 1992 |
